Trump wanted FDA approval for psychedelic therapies. Heidi Overton advised on policy regarding the executive order, which led to team submissions to the Domestic Policy Council.
1 report, 1 independent
Updated Jul 24
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Trump wanted FDA approval for psychedelic therapies. Heidi Overton advised on policy regarding the executive order, which led to team submissions to the Domestic Policy Council.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Donald Trump
American businessman and politician (born 1946), President of the United States (2017–2021; since 2025)
- FDA
-
Department of Health & Human Services
government department in the state of Victoria, Australia
- The FDA reviewed risks and loosened the label on testosterone replacement therapy (TRT) following an attempt by the Trump administration to reverse its decline.
- The Trump administration plans to dismantle the Office for Civil Rights and shift its civil rights enforcement duties to the Justice Department.
Related events
- Trump is expected to nominate Heidi Overton to lead the Food and Drug Administration.
- NIH cuts budgets and personnel, impacting funded research leading to FDA-approved treatments.
- A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.
- FDA approval is the goal for product candidates from Daré Bioscience, Inc.
- Fox News reports on agency actions and challenges as the FDA nominee faces confirmation hearing pressure.
Coverage
Newest first; wire copies grouped- alternet.orgJoe Rogan threatened to no-show Oval Office event amid 'messy' fight with key Trump aide